About Remo Moomiaie
Form D filings for Cytonus Therapeutics from 2018 to 2023 list Remo Moomiaie as chief executive officer and director.
Remo Moomiaie first appears on SEC filings in 2018.
Experience
This experience comes from SEC filings. The years are when the filings name Remo Moomiaie in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Remo Moomiaie works with at each company, as listed on that company's latest Form D.
Cytonus Therapeutics, Inc. · Form D, Nov 6, 2023